Lyon, France

Poxel S.a.s.


USPTO Granted Patents = 6

% Expired Patents = 50.0



Forward Citations = 25

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Daniel Cravo (5 out of 26 patents)

silverMedal Didier Mesangeau (4 out of 13 patents)

bronzeMedal Gérard Moinet (3 out of 26 patents)

4.  Annick Audet (2 out of 8 patents)

5.  Matthias Helmreich (1 out of 3 patents)

6.  Mike Brandner (1 out of 1 patent)

7.  Thierry Passemar (1 patent)

8.  Bernard Boudet (2 patents)

9.  Mike Brandner (0 patent)

10.  Stéphanie Aubourg (0 patent)


6 patents:

Company Overview
Poxel S.a.s. is a dynamic biopharmaceutical company that specializes in the development of innovative treatments for metabolic diseases. With a focus on type 2 diabetes and rare genetic disorders, Poxel aims to provide new therapeutic options for patients worldwide. Leveraging its expertise in mitochondrial dysfunction and insulin signaling pathways, the company is committed to advancing cutting-edge research and bringing novel therapies to market.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#48 in Lyon

#2,491 in France

Lyon, FR
Lyon, France
Forward Citations = 25

6 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Poxel S.a.s.. Retrieved from https://idiyas.com/company/poxel-s-a-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…